Lee Chan Henry's Form 4 filing
BeOne Medicines Ltd. (ONC) · filed May 15, 2026
- Accession no.
- 0001980648-26-000012
- Filed
- May 15, 2026
- Trade date
- May 13, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $103.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lee Chan HenryCIK 0001980648 | Officer (SVP, General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | American Depositary Shares | MOption exerciseAcquired | +101 | $194.47 | +$19,641.47 | 101 | Direct | |
| May 13, 2026 | American Depositary Shares | MOption exerciseAcquired | +133 | $213.32 | +$28,371.56 | 234 | Direct | |
| May 13, 2026 | American Depositary Shares | MOption exerciseAcquired | +98 | $159.03 | +$15,584.94 | 332 | Direct | |
| May 13, 2026 | American Depositary Shares | SSaleDisposed | −332 | $310.72 | −$103,159.04 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | Ordinary Shares | MOption exerciseDisposed | −1,313 | $0.00 | $0 | 19,864 | Direct | |
| May 13, 2026 | Ordinary Shares | MOption exerciseDisposed | −1,729 | $0.00 | $0 | 83,226 | Direct | |
| May 13, 2026 | Ordinary Shares | MOption exerciseDisposed | −1,274 | $0.00 | $0 | 107,848 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.